Certified by Founder Lodge
Alchemab Therapeutics Ltd
United Kingdom - London, England
START UP
1 Disclosed Funding Rounds $0
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of hard-to-treat disease in a unique and transformative approach to drug discovery and developm
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| September, 10 ,2025 | Series A | Undisclosed Amount |
SV Health Investors
Lightstone Ventures
DCVC Bio
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Govstream.ai | $3,600,000 | (Dec 5, 2025)
ZincFive, Inc. | $30,000,000 | (Dec 5, 2025)
imper.ai | $28,000,000 | (Dec 5, 2025)
SPhotonix Inc | $4,500,000 | (Dec 5, 2025)
Multifactor (YC F25) | $15,000,000 | (Dec 5, 2025)
